CN Patent

CN116966166A — 碳酸氢钠原位转化驱动胺药物的透皮递送

Assigned to Corian Co ltd · Expires 2023-10-31 · 3y expired

What this patent protects

本发明提供了碳酸氢钠原位转化驱动胺药物的透皮递送，提供了用于透皮给予活性剂的盐形式而不是其中性形式的组合物、装置和方法。

USPTO Abstract

本发明提供了碳酸氢钠原位转化驱动胺药物的透皮递送，提供了用于透皮给予活性剂的盐形式而不是其中性形式的组合物、装置和方法。

Drugs covered by this patent

donepezil-hydrochloride (DONEPEZIL HYDROCHLORIDE)

Patent Metadata

Patent number: CN116966166A
Jurisdiction: CN
Classification: —
Expires: 2023-10-31
Drug substance claim: No
Drug product claim: No
Assignee: Corian Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.